217 related articles for article (PubMed ID: 30144071)
1. Src mediates TGF-β-induced intraocular pressure elevation in glaucoma.
Tsukamoto T; Kajiwara K; Nada S; Okada M
J Cell Physiol; 2019 Feb; 234(2):1730-1744. PubMed ID: 30144071
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
3. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
4. Vertebrate Lonesome Kinase Regulated Extracellular Matrix Protein Phosphorylation, Cell Shape, and Adhesion in Trabecular Meshwork Cells.
Maddala R; Skiba NP; Rao PV
J Cell Physiol; 2017 Sep; 232(9):2447-2460. PubMed ID: 27591737
[TBL] [Abstract][Full Text] [Related]
5. Silibinin attenuates TGF-β2-induced fibrogenic changes in human trabecular meshwork cells by targeting JAK2/STAT3 and PI3K/AKT signaling pathways.
Wu X; Liang J; Liu J; Huang Y; Zhang L; Liu X; Guo J; Zhang M; Chen Y; Wang J
Exp Eye Res; 2024 Jul; 244():109939. PubMed ID: 38789021
[TBL] [Abstract][Full Text] [Related]
6. Ocular hypotensive efficacy of Src-family tyrosine kinase inhibitors via different cellular actions from Rock inhibitors.
Kirihara T; Shimazaki A; Nakamura M; Miyawaki N
Exp Eye Res; 2014 Feb; 119():97-105. PubMed ID: 24321889
[TBL] [Abstract][Full Text] [Related]
7. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure.
Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314
[TBL] [Abstract][Full Text] [Related]
8. Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.
Somvanshi RK; Zou S; Kadhim S; Padania S; Hsu E; Kumar U
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166325. PubMed ID: 34921975
[TBL] [Abstract][Full Text] [Related]
9. Effects of TGF-β2 on cadherins and β-catenin in human trabecular meshwork cells.
Wecker T; Han H; Börner J; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6456-62. PubMed ID: 24003087
[TBL] [Abstract][Full Text] [Related]
10. TGF-β2-induced invadosomes in human trabecular meshwork cells.
Han H; Kampik D; Grehn F; Schlunck G
PLoS One; 2013; 8(8):e70595. PubMed ID: 23940598
[TBL] [Abstract][Full Text] [Related]
11. The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma.
Wordinger RJ; Sharma T; Clark AF
J Ocul Pharmacol Ther; 2014; 30(2-3):154-62. PubMed ID: 24517218
[TBL] [Abstract][Full Text] [Related]
12. Rho GTPase signaling promotes constitutive expression and release of TGF-β2 by human trabecular meshwork cells.
Pervan CL; Lautz JD; Blitzer AL; Langert KA; Stubbs EB
Exp Eye Res; 2016 May; 146():95-102. PubMed ID: 26743044
[TBL] [Abstract][Full Text] [Related]
13. The role of TGF-β in the pathogenesis of primary open-angle glaucoma.
Fuchshofer R; Tamm ER
Cell Tissue Res; 2012 Jan; 347(1):279-90. PubMed ID: 22101332
[TBL] [Abstract][Full Text] [Related]
14. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-β2 signaling pathways.
Razali N; Agarwal R; Agarwal P; Froemming GRA; Tripathy M; Ismail NM
Eur J Pharmacol; 2018 Nov; 838():1-10. PubMed ID: 30171854
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering.
Hassan MDS; Razali N; Abu Bakar AS; Abu Hanipah NF; Agarwal R
Exp Biol Med (Maywood); 2023 Aug; 248(16):1425-1436. PubMed ID: 37873757
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
17. The TGFβ Induced MicroRNAome of the Trabecular Meshwork.
Doyle C; Callaghan B; Roodnat AW; Armstrong L; Lester K; Simpson DA; Atkinson SD; Sheridan C; McKenna DJ; Willoughby CE
Cells; 2024 Jun; 13(12):. PubMed ID: 38920689
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.
Inoue-Mochita M; Inoue T; Kojima S; Futakuchi A; Fujimoto T; Sato-Ohira S; Tsutsumi U; Tanihara H
J Biol Chem; 2018 Jul; 293(28):10975-10984. PubMed ID: 29752408
[TBL] [Abstract][Full Text] [Related]
19. Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2.
Medina-Ortiz WE; Belmares R; Neubauer S; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6779-88. PubMed ID: 24030464
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
